Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/07/23 04:20:00 on US and Canada Markets.
ALPHARETTA, Ga., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ® ), announced today that multiple oral and poster present...
Record Quarterly Net Revenue of $50 Million for Q3 2023, Up 48% from Q3 2022 Raises Full-Year 2023 Net Revenue Guidance from $185 to $195 Million to $194 to $198 Million Operating Use of Cash in Q3 of $0.9 Million, Demonstrating Continued Progress Towards Achieving Profitability ...
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
BROOKFIELD News, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) and its listed affiliate Brookfield Business Partners (NYSE: BBU; TSX: BBU.UN) today announced the completion of the sale of Westinghouse Electric Company (“Westinghouse” or “...
BROOKFIELD News, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) and its listed affiliate Brookfield Business Partners (NYSE: BBU; TSX: BBU.UN) today announced the completion of the sale of Westinghouse Electric Company (“Westinghouse” or “...
BROOKFIELD News, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) and its listed affiliate Brookfield Business Partners (NYSE: BBU; TSX: BBU.UN) today announced the completion of the sale of Westinghouse Electric Company (“Westinghouse” or “...
sBLA based on Phase 4 study which assessed pharmacokinetic similarity between two treatment groups: multi-switching group alternating between Humira and high-concentration HADLIMA vs. Humira-continued group Filing acceptance reinforces Samsung Bioepis and Organon’s commitment to pr...
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that, for the second year in a row, it has been named a BioSpace 2024 Best Place to Work in the small empl...
Apollo Medical Holdings, Inc. Reports Third Quarter 2023 Results PR Newswire Company to Host Conference Call on Tuesday, November 7, 2023 , at 2:30 p.m. PT / 5:30 p.m. ET ALHAMBRA, Calif. , Nov. 7, 2023 /PRNewswire/ -- Apollo Medical Holdings,...
DENVER, CO / ACCESSWIRE / November 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financial results for its first quarter of fiscal year 2024 for the period ended September 30, 2023, after ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
11.05%Change Percent:
F5 Inc. Company Name:
FFIV Stock Symbol:
NASDAQ Market:
f5.com Website: